ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,886.61
-0.29%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Psychemedics Corporation (PMD)

  7. Psychemedics Corporation (PMD) News

PMD

Psychemedics (PMD)

Psychemedics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PMD
DateTimeSourceHeadlineSymbolCompany
15/05/202407:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMDPsychemedics Corporation
15/05/202406:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
15/05/202406:55GlobeNewswire Inc.Psychemedics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:PMDPsychemedics Corporation
28/03/202423:20GlobeNewswire Inc.Psychemedics Corporation Reports 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
22/03/202400:00GlobeNewswire Inc.Psychemedics Recognized as a Top 10 Employee Health Testing Services ProviderNASDAQ:PMDPsychemedics Corporation
14/02/202401:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMDPsychemedics Corporation
03/02/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMDPsychemedics Corporation
27/01/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
25/01/202409:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
03/01/202403:27GlobeNewswire Inc.Psychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasNASDAQ:PMDPsychemedics Corporation
20/12/202308:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
15/12/202304:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMDPsychemedics Corporation
28/11/202303:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
28/11/202301:00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:PMDPsychemedics Corporation
14/11/202309:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMDPsychemedics Corporation
10/11/202309:00GlobeNewswire Inc.Psychemedics Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
10/11/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
09/11/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
28/10/202302:00GlobeNewswire Inc.Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenNASDAQ:PMDPsychemedics Corporation
26/09/202308:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
26/09/202307:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
23/09/202303:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
22/09/202307:00GlobeNewswire Inc.Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerNASDAQ:PMDPsychemedics Corporation
01/09/202307:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
23/08/202307:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
23/08/202307:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PMDPsychemedics Corporation
22/08/202307:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
22/08/202307:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
22/08/202307:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
22/08/202307:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
 Showing the most relevant articles for your search:NASDAQ:PMD

Your Recent History

LSE
TRAF
Trafalgar Property
USOTC
TMPOQ
Tempo Automation (CE)
LATK
BAKEUSDT
BakeryToken
BIT
UC5F08
Unicredit Bank
COIN
HYCUSD
COIN
NDXXETH
Indexed
USOTC
MAGP
Magplane Technology (CE)
NYSE
GEP
GE Cap Pines
AMEX
JJS
iPath Series B Bloomberg...
NASDAQ
PXUS
COIN
PLURAGBP
BIT
UC8XW7
Unicredit Bank
LSE
DESC
LSE
0K2U
Real Estate Investments ...
USOTC
RRRI
Rock Ridge Resources (CE)
ASX
PTL
Prestal
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved